BioAge Labs, Inc.
BIOA
Jodie situation report
BioAge Labs, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 18 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 9 directly disclosed connections are confirming.
- BIOA's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if BIOA's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind BIOA
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
NVSNovartis AGpartnerMay 8, 2026 ▾
“We are also advancing earlier stage platform-derived programs in collaboration with Eli Lilly and Company (Lilly), and have an ongoing target discovery collaboration with Novartis Pharma AG (Novartis).”
LLYEli Lilly and CompanypartnerMay 8, 2026 ▾
“We are also advancing earlier stage platform-derived programs in collaboration with Eli Lilly and Company (Lilly), and have an ongoing target discovery collaboration with Novartis Pharma AG (Novartis).”
AZNAstraZeneca PLCpartnerMar 24, 2026 ▾
“However, we are aware of NLRP3 inhibitor pipeline programs including those from Ventyx Biosciences (pending acquisition by Eli Lilly), NodThera, Roche, Merck, Novo Nordisk, AstraZeneca, Neumora, Ventus, Tenvie, Insilico, Brenig, and Zydus.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 8 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
BIOA is currently a Follower in the organic co-movement group Biotech and Energy. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for BIOA; it is not active in the latest market snapshot.